Author: oncologs.com

Background and Aims Credit: Yazan Abboud, Nikolaos T. Pyrsopoulos Background and Aims Over the past two decades, there has been a significant increase in the incidence of primary liver cancer in the USA, with higher rates observed in men. Its burden increases with age and disproportionately

The University of Cincinnati Cancer Center is the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.  Credit: Photo/UC Health The University of Cincinnati Cancer Center is the first site in the Midwest

URBANA, Ill. — The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and enlarged prostate in millions of men worldwide. But a new University of Illinois Urbana-Champaign study suggests the drug may also provide a surprising and life-saving benefit: lowering cholesterol

“In sum, we have defined what a premature aging disease is and developed tools to allow diagnostics of patients and disease population.” Credit: 2024 Worm et al. “In sum, we have defined what a premature aging disease is and developed tools to allow diagnostics of

Researchers have developed a revolutionary biosensor using terahertz (THz) waves that can detect skin cancer with exceptional sensitivity, potentially paving the way for earlier and easier diagnoses. Published in the IEEE Transactions on Biomedical Engineering, the study presents a significant advancement in early cancer detection,

The parents of millions of teens have no intention of getting their children vaccinated against the human papillomavirus (HPV). Parents with higher socioeconomic status are less likely than parents of lower income or educational attainment to plan to vaccinate their children. Credit: MUSC Hollings Cancer

A new partnership between a Pennington Biomedical physician-researcher at the Metamor Institute and an LSU School of Medicine oncologist has already saved women’s lives in southeast Louisiana. Credit: Ernie Ballard/PBRC A new partnership between a Pennington Biomedical physician-researcher at the Metamor Institute and an LSU

Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called fibroblasts, according to research led by investigators from the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins Bloomberg School of

“Estimates of the frequency of NTRK gene fusion in large cohorts of patients with solid tumors come from a limited number of studies. […]. We aimed to address this gap by evaluating patients with papillary thyroid cancer (PTC) from Finland […]” Credit: 2024 Zhang et

To prevent an emerging genomic technology from contributing to health disparities, a scientific team funded by the National Institutes of Health has devised new ways to improve a genetic testing method called a polygenic risk score. Since polygenic risk scores have not been effective for